Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $179.85 million. The enterprise value is $82.50 million.

Market Cap	179.85M
Enterprise Value	82.50M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

ABOS has 72.23 million shares outstanding. The number of shares has increased by 1.73% in one year.

Current Share Class	72.23M
Shares Outstanding	72.23M
Shares Change (YoY)	+1.73%
Shares Change (QoQ)	+4.37%
Owned by Insiders (%)	14.54%
Owned by Institutions (%)	25.74%
Float	37.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.06
P/TBV Ratio	2.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.35.

Current Ratio	4.55
Quick Ratio	4.39
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.84

Financial Efficiency

Return on equity (ROE) is -93.23% and return on invested capital (ROIC) is -47.15%.

Return on Equity (ROE)	-93.23%
Return on Assets (ROA)	-42.37%
Return on Invested Capital (ROIC)	-47.15%
Return on Capital Employed (ROCE)	-109.78%
Weighted Average Cost of Capital (WACC)	6.73%
Revenue Per Employee	n/a
Profits Per Employee	-$1.86M
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +137.14% in the last 52 weeks. The beta is 0.32, so ABOS's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+137.14%
50-Day Moving Average	2.72
200-Day Moving Average	2.11
Relative Strength Index (RSI)	45.95
Average Volume (20 Days)	297,930

Short Selling Information

The latest short interest is 1.55 million, so 2.14% of the outstanding shares have been sold short.

Short Interest	1.55M
Short Previous Month	1.06M
Short % of Shares Out	2.14%
Short % of Float	4.17%
Short Ratio (days to cover)	1.63

Income Statement

Revenue	n/a
Gross Profit	-104.89M
Operating Income	-114.61M
Pretax Income	-113.28M
Net Income	-113.28M
EBITDA	-114.56M
EBIT	-114.61M
Earnings Per Share (EPS)	-$1.85

Balance Sheet

The company has $128.40 million in cash and $31.05 million in debt, with a net cash position of $97.35 million or $1.35 per share.

Cash & Cash Equivalents	128.40M
Total Debt	31.05M
Net Cash	97.35M
Net Cash Per Share	$1.35
Equity (Book Value)	87.48M
Book Value Per Share	1.21
Working Capital	103.87M

Cash Flow

In the last 12 months, operating cash flow was -$105.55 million and capital expenditures -$9,000, giving a free cash flow of -$105.55 million.

Operating Cash Flow	-105.55M
Capital Expenditures	-9,000
Depreciation & Amortization	55,000
Net Borrowing	n/a
Free Cash Flow	-105.55M
FCF Per Share	-$1.46

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.73%
Shareholder Yield	-1.73%
Earnings Yield	-62.98%
FCF Yield	-58.69%

Analyst Forecast

The average price target for ABOS is $8.00, which is 221.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	221.29%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2